<DOC>
	<DOC>NCT01987895</DOC>
	<brief_summary>This clinical study is conducted to assess the efficacy of cadazolid compared to vancomycin in subjects with Clostridium difficile-associated diarrhea (CDAD).</brief_summary>
	<brief_title>Efficacy and Safety of Cadazolid Versus Vancomycin in Subjects With Clostridium Difficile - Associated Diarrhea</brief_title>
	<detailed_description>Subjects selected to participate in the study are treated either with cadazolid or vancomycin for 10 days. At the end of treatment, clinical cure is assessed; subjects are then followed-up to assess any disease recurrence.</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Oxazolidinones</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Signed Informed Consent. Male or female â‰¥ 18 years of age. Females of childbearing potential must agree to use an adequate and reliable method of contraception. Subject with a diagnosis of mildmoderate or severe CDAD (first occurrence or first recurrence within 3 months) with: Diarrhea: a change in bowel habits with &gt; 3 liquid or unformed bowel movements (UBM) within 24 hours prior to randomization, AND Positive C. difficile toxin test on a stool sample produced within 72 hours prior to randomization. More than one previous episode of CDAD in the 3month period prior to randomization. Evidence of lifethreatening or fulminant CDAD. Likelihood of death within 72 hours from any cause. History of inflammatory colitides, chronic abdominal pain, or chronic diarrhea. Antimicrobial treatment active against CDAD administered for &gt; 24 hours except for metronidazole treatment failures (MTF) Known hypersensitivity or contraindication to study drugs, oxazolidinones, or quinolones. Unable or unwilling to comply with all protocol requirements. Any circumstances or conditions, which, in the opinion of the investigator, may affect full participation in the study or compliance with the protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Post-antibiotic diarrhea</keyword>
	<keyword>Clostridium difficile infection</keyword>
</DOC>